Loading...

Loading...

J&J, Medtronic, Novo Nordisk in the Spotlight: The Week in Health
By Sofía Garduño - Thu, 07/24/2025 - 08:59
This week J&J files for psoriasis drug, Medtronic expands device use in the European Union, and Novo Nordisk launches an e-commerce store in Mexico.
https://mexicobusiness.news/tag/johnson-johnson
More Health
J&J Files for FDA Approval of Oral Psoriasis Drug Icotrokinra
By Sofía Garduño - Tue, 07/22/2025 - 08:17
J&J submits NDA for icotrokinra, an oral IL-23 blocker for plaque psoriasis, based on four Phase 3 trials showing strong efficacy and safety.
Patient Centricity a Pathway to Humane Healthcare
By Víctor Matos - Thu, 06/19/2025 - 07:30
Mexico must adopt patient-centered care and medtech tools to improve access, satisfaction, and health outcomes, writes Víctor Matos.
Forum Salud 2025 Highlights Role of Tech in Healthcare’s Future
By Sofía Garduño - Fri, 05/30/2025 - 10:00
Mexico’s Forum Salud Digital 2025 spotlighted AI and tech as key drivers for a more efficient, interoperable, and value-based healthcare system.
Is Mexico Pioneering Next-Generation Surgical Techniques?
By Víctor Matos - Tue, 04/08/2025 - 06:30
The advancement of science and technology has profoundly transformed the field of medicine. Mexico is part of this revolution, writes Víctor Matos.
Why Multiventure Strategy Won’t Work For Most Entrepreneurs
By Guillermo Pepe - Tue, 03/25/2025 - 06:00
Entrepreneurial success comes from deep focus, not multitasking. Visionaries like Musk and Bezos mastered one venture first, writes Guillermo Pepe.
Mexico’s AI Growth to be Limited by Energy Challenges: AI Week
By Diego Valverde - Thu, 03/20/2025 - 09:45
Morelos boosts AI training with IPIA and IMMUNE, Samsung Mexico launches its AI Academy, and an AI-powered lung biopsy approval advances healthcare.
Nipocalimab Data Shows Promise for IgG-driven Diseases: J&J
By MBN Staff - Mon, 02/17/2025 - 08:00
Johnson & Johnson’s new data on nipocalimab shows its high-affinity binding, supporting its potential for IgG-driven alloantibody diseases

FDA Approves Johnson & Johnson’s Varipulse Device for AFib
By MBN Staff - Fri, 11/15/2024 - 10:15
FDA approves Johnson & Johnson's Varipulse device for drug-refractory atrial fibrillation, expanding treatment options for heart rhythm disorders.

Market Access Shake-Up: Medicine, Generics, Medical Devices
By Diego Valverde - Wed, 09/11/2024 - 11:50
Mexico’s healthcare system faces barriers like regulatory hurdles and market entry issues, delaying access to medicines and devices, say experts.